I B Pharma Private Limited, a active private limited company, was established on 08 August 2007 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397DL2007PTC166799. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.76 M.
It upholds a compliant status. Employing 5 professional, Its leadership includes Ritu Goyal (Director), Manoj Goyal (Director). Past directors included Nitin Kansal, Ritu Goyal, Inder Bhushan Kansal. It holds ₹25.27 Cr open charges and ₹12.87 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No.2, Plot No. E-22,, Block-B-1, Upper Ground Floor, Mohan Cooperative Industrial Estate, Mathura Road,, New Delhi, Delhi, 110044.
U51397DL2007PTC166799
166799
08 August 2007
₹1.00 M
₹0.76 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into I B Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ritu Goyal | Director | 13 Aug 2020 | Current |
| Manoj Goyal | Director | 13 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 14 Aug 2020 | Past |
| Pramod Abcsdd | Additional Director | 13 Aug 2020 | Past |
| Pramod Abcsdd | Director | 30 Oct 2007 | Past |
| Pramod Abcsdd | Director | 01 Jan 2009 | Past |
| Pramod Abcsdd | Additional Director | 13 Aug 2020 | Past |
| Pramod Abcsdd | Additional Director | 14 Aug 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
I B Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.22% increase. The company also saw a substantial improvement in profitability, with a 95.06% increase in profit. The company's net worth Soared by an impressive increase of 22.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, I B Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹252,727,000.00
₹128,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2025 | Others | ₹14.00 Cr | Open |
| 04 May 2024 | Hdfc Bank Limited | ₹8.60 Cr | Open |
| 24 Aug 2021 | Hdfc Bank Limited | ₹2.43 M | Open |
| 27 Jun 2015 | Yes Bank Limited | ₹2.43 Cr | Open |
| 25 Nov 2022 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
I B Pharma has a workforce of 5 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of I B Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped I B Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 140.00 M with Charge ID 101154339 was registered on 01 Aug 2025. was recorded as a recent event.
The activity A charge with Yes Bank Limited of Rs. 24.30 M registered on 27 Jun 2015 with Charge ID 10583913 was modified on 06 Jan 2025. was completed.
The activity I B Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 86.00 M with Charge ID 100925748 was registered on 04 May 2024. was recorded as a recent event.
Progress on I B Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge registered on 25 Nov 2022 via Charge ID 100654307 with Others was fully satisfied on 27 Apr 2023. was completed.
The CIN of I B Pharma Private Limited is U51397DL2007PTC166799.
I B Pharma Private Limited is headquartered at Office No.2, Plot No. E-22,, Block-B-1, Upper Ground Floor, Mohan Cooperative Industrial Estate, Mathura Road,, New Delhi, Delhi, 110044.
I B Pharma Private Limited was incorporated on 08 August 2007.
The current directors of I B Pharma Private Limited are
The primary industry of I B Pharma Private Limited is Trade.
I B Pharma Private Limited is unlisted.
The authorized capital of I B Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.76 M.
The compliance status of I B Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX